Share
FOX 13's Craig Patrick sits down with U.S. Rep. Anna Paulina Luna to talk about her campaign.
TAMPA, Fla.-U.S. Representative Anna Paulina Luna sat down with FOX 13 for a wide-ranging, one-on-one interview covering some of the most pressing and controversial issues facing the nation and Florida. From stunning claims about non-human technology and missing Jeffrey Epstein files to the complexities of foreign conflicts and federally subsidized flood insurance crisis, the Pinellas congresswoman offered candid insights into her legislative priorities and what she said she is finding behind the scenes in Washington.
As the chair of the Task Force on Declassification of Federal Secrets, Rep. Luna offered a stunning assessment of Unidentified Anomalous Phenomena (UAPs). When asked if some UAPs are derived from non-human intelligence, Luna did not hesitate.
"I do believe that there's technology out there not created by human beings that we have been able to observe in various capacities," Luna stated, adding that evidence can now be found on Department of Defense websites. When asked whether these phenomena involve "interdimensional beings," Luna said "based on what we've received, (the) testimony, and then also just with how some of this technology moves, we have no other way of explaining it."
Interestingly for Floridians, she noted that the Tampa Bay and Bradenton areas are hotspots for these sightings, dismissing the idea that the phenomena are simply secret U.S. government tech and suggesting that locals who look up at the skies "might see something interesting."
Regarding the ongoing conflict with Iran, Luna was asked if—with the full benefit of hindsight—ordering the U.S.-led attacks on February 28th was the right call.
"I think given the intelligence that was presented that they are going to be striking our bases and that we were going to [be] receiving mass casualty, yes, I think that he made the correct decision," Luna answered.
While she defended the U.S. attacks, Luna stood firm against deploying American ground forces.
"The president has been very clear that he's not going to put boots on the ground," she said, emphasizing a strategy that relies on allies for physical intervention while the U.S. focuses on peace negotiations.
On domestic health policy, Luna praised Florida Surgeon General Dr. Joseph Ladapo and strongly advocated for parental choice regarding childhood vaccines. She argued against vaccine requirements for children attending public schools, pointing to the adverse effects some individuals experienced during the COVID-19 pandemic.
Luna also criticized the pharmaceutical industry's grip on Congress. "No other industry has the claw that the pharmaceutical industry has on representatives," she said, pointing to campaign contributions and PAC money as roadblocks to holding drug manufacturers accountable or exploring alternative treatments for conditions like PTSD and postpartum depression.
When pressed on whether President Trump’s tariffs are ultimately a net positive for the U.S. economy, Rep. Luna argued that they serve as an essential leverage tool through reciprocal tariffs. While acknowledging initial friction—such as ongoing trade disputes with Canada—Luna stated that tariffs prove to be a net positive once negotiations force foreign countries to lower their tax rates on American products sold overseas.
To address domestic affordability, Luna pointed to the One Big Beautiful Bill, a sweeping legislative package containing cuts to eliminate taxes on tips, overtime, and Social Security, as well as an expansion of the child tax credit. She also voiced support for capping credit card interest rates and prescription drug prices, pointing to heavy corporate lobbying as the primary obstacle preventing broader congressional support for those consumer caps.
One of Luna’s most prominent legislative efforts has been her push to ban members of Congress from trading individual stocks. She criticized the current system, where she said lawmakers sit on committees that grant them early access to lucrative contract information.
